Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Jul 14;117(28):16109-16111.
doi: 10.1073/pnas.2010212117. Epub 2020 Jun 30.

Turning up the heat on HIV-1

Irene P Chen  1   2 , Melanie Ott  3   4
Affiliations
Comment

Turning up the heat on HIV-1

Irene P Chen et al. Proc Natl Acad Sci U S A. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interest.

Figures

Fig. 1.
Fig. 1.
KRIBB11 reveals differences in latency reversal in immortalized vs. primary T cells. In immortalized J-Lat cells, KRIBB11 can block the latency-reversing abilities of most LRAs (bryostatin, panobinostat, romidepsin, HBB2, bortezomib, and PMA/I) by inhibiting the recruitment of CycT1, which partners with HSF1 to induce HIV-1 transcription elongation. In patient cells, chemical stressors (disulfiram, HBB2, bortezomib, tricyclic bis[cyano enone] [TBE-31], and Shikonin) known to activate HSF1 are unable to reverse HIV-1 latency, perhaps due to low levels of CycT1 in primary cells compared with J-Lats. By contrast, PMA/I reactivates HIV-1 by increasing the expression of CycT1. As a result, KRIBB11 is able to inhibit PMA/I’s LRA function.
See this image and copyright information in PMC

Comment on

References

    1. Timmons A, et al. . HSF1 inhibition attenuates HIV-1 latency reversal mediated by several candidate LRAs in vitro and ex vivo. Proc. Natl. Acad. Sci. U.S.A. 117, 15763–15771 (2020). - PMC - PubMed
    1. Jordan A., Bisgrove D., Verdin E., HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 22, 1868–1877 (2003). - PMC - PubMed
    1. Jordan A., Defechereux P., Verdin E., The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. EMBO J. 20, 1726–1738 (2001). - PMC - PubMed
    1. Spina C. A., et al. , An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients. PLoS Pathog. 9, e1003834 (2013). - PMC - PubMed
    1. Ait-Ammar A., et al. , Current status of latency reversing agents facing the heterogeneity of HIV-1 cellular and tissue reservoirs. Front. Microbiol. 10, 3060 (2020). - PMC - PubMed

Publication types

LinkOut - more resources